🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
There is no standard treatment for chondrosarcoma. Some small sample of stu...
Status
Unknown
Location
The Second Affiliated Hospital of Zhejiang University School of Medicine
Start Date
2023-02-06
Trial ID
NCT05193188
Treatments Being Tested
Anlotinib is a multi-target receptor tyrosine kinase inhibitor in domestic ...
Status
Unknown
Location
Multiple Locations
Start Date
2018-11-30
Trial ID
NCT03750916
Treatments Being Tested
This is an Open, Single Arm, Exploratory and Phase II Clinical Trial of Anl...
Status
Recruiting
Location
Jiangxi Cancer Hospital
Start Date
2022-06-02
Trial ID
NCT05252078
Treatments Being Tested
Research purposes: the research design in the late more than 2 lines TNBC p...
Status
Recruiting
Location
Tianjin Cancer Hospital Airport Hospital
Start Date
2024-12-06
Trial ID
NCT06878625
This study was designed to investigate the efficacy and side effects of com...
Status
Unknown
Location
Multiple Locations
Start Date
2019-04-01
Trial ID
NCT03890055
Treatments Being Tested
This is a single-arm, open-label and exploratory clinical study of Anlotini...
Status
Unknown
Location
Jiangsu Province Hospital
Start Date
2019-06-10
Trial ID
NCT04052152
Treatments Being Tested
Anlotinib is a multi-target receptor tyrosine kinase inhibitor in domestic ...
Status
Unknown
Location
Shandong Cancer Hospital
Start Date
2020-11-04
Trial ID
NCT04619563
Treatments Being Tested
To observe the efficacy and safety of hydrochloride anlotinib combined with...
Status
Unknown
Location
Multiple Locations
Start Date
2023-07-01
Trial ID
NCT05772377
Treatments Being Tested
To evaluate the efficacy and safety of Anlotinib Hydrochloride in Combinati...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2020-01-01
Trial ID
NCT04300959
This is An Open, Single Arm, Multicenter, Exploratory Phase II study, to ev...
Status
Unknown
Location
Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University)
Start Date
2022-01-06
Trial ID
NCT05111366
Treatments Being Tested